shortagewatch

Home / Cancer and immune system / Oxaliplatin

ATC L01XA03 · Antineoplastic Agents

Oxaliplatin shortage

As of 31 Oct 2026, Oxaliplatin has a reported shortage in 5 of the 5 countries we track (Germany, Italy, Spain, Austria, Belgium), covering 11 products.

Countries5/5
Products11packs or presentations
Short since24 Feb 202520 months ago
Earliest return21 Nov 2026company estimate
No return date6products
Main reasonManufacturing problem
Germany1 pack shortItaly6 packs shortSpain2 packs shortAustria1 pack shortBelgium1 pack short

Timeline

GermanyItalySpainAustriaBelgium
20262027Oxaliplatin Accord 5 mg/ml Konzentrat zur HeOxaliplatin Accord 5 mg/ml Konzentrat zur Herstellung einer InfusionslösungOXALIPLATINO ACCORDOXALIPLATINO ACCORDOXALIPLATINO AUROBINDO ITALIAOXALIPLATINO AUROBINDO ITALIAOXALIPLATINO AUROBINDO ITALIAOXALIPLATINO AUROBINDO ITALIAOXALIPLATINO ACCORDOXALIPLATINO ACCORDOXALIPLATINO SUNOXALIPLATINO SUNOXALIPLATINO AUROBINDO ITALIAOXALIPLATINO AUROBINDO ITALIAOXALIPLATINO ACCORD 5 mg/ml CONCENTRADO PARAOXALIPLATINO ACCORD 5 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 1 vial de 10 mlOXALIPLATINO HIKMA 5 MG/ML CONCENTRADO PARA OXALIPLATINO HIKMA 5 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 1 vial de 20 mlOxaliplatin Accord 5 mg/ml Konzentrat zur HeOxaliplatin Accord 5 mg/ml Konzentrat zur Herstellung einer Infusionslösung, 1 StückOxaliplatin Accord Healthcare 5 mg/ml inf. sOxaliplatin Accord Healthcare 5 mg/ml inf. sol. (conc.) i.v. vial 10 mltoday

Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.

Affected products

CountryProductHolderSinceExpected backReason
DEOxaliplatin Accord 5 mg/ml Konzentrat zur Herstellung einer InfusionslösungAccord Healthcare B.V.31 Jul 202631 Dec 2026Manufacturing problem
Probleme in der Herstellung
ITOXALIPLATINO ACCORDACCORD HEALTHCARE, S.L.U.24 Feb 2025not givenManufacturing problem
Problemi produttivi: ridotta disponibilità
ITOXALIPLATINO AUROBINDO ITALIAEugia Pharma (Malta) Limited8 Mar 2026not givenManufacturing problem
Problemi produttivi
ITOXALIPLATINO AUROBINDO ITALIAEugia Pharma (Malta) Limited30 Aug 2026not givenManufacturing problem
Problemi produttivi
ITOXALIPLATINO ACCORDACCORD HEALTHCARE, S.L.U.30 Sep 2026not givenCommercial decision or withdrawal
Motivi commerciali
ITOXALIPLATINO SUNSUN PHARMA FRANCE1 Oct 2026not givenIncreased demand
Elevata richiesta: distribuzione contingentata
ITOXALIPLATINO AUROBINDO ITALIAEugia Pharma (Malta) Limited9 Oct 2026not givenIncreased demand
Elevata richiesta/problemi produttivi
ESOXALIPLATINO ACCORD 5 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 1 vial de 10 mlAccord Healthcare S.L.U.7 Jan 202630 Dec 2026Not stated
ESOXALIPLATINO HIKMA 5 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 1 vial de 20 mlHikma Farmaceutica (Portugal) S.A.29 Jun 202621 Nov 2026Not stated
ATOxaliplatin Accord 5 mg/ml Konzentrat zur Herstellung einer Infusionslösung, 1 StückAccord Healthcare B.V.19 Jun 202631 Dec 2026Increased demand
Erhöhter Mehrbedarf
BEOxaliplatin Accord Healthcare 5 mg/ml inf. sol. (conc.) i.v. vial 10 mlAccord Healthcare14 Aug 202627 Dec 2026Manufacturing problem
Delay in production

"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.

Related medicines also in short supply

Carboplatin Cisplatin